<DOC>
	<DOCNO>NCT03092739</DOCNO>
	<brief_summary>The primary purpose non-interventional , multinational study assess feasibility assess PD-L1 protein expression cytological sample surrogate histological sample obtain participant stage non-small cell lung cancer ( NSCLC ) small cell lung cancer ( SCLC ) .</brief_summary>
	<brief_title>A Study Assess Programmed Death Ligand-1 ( PD-L1 ) Expression Cytological Versus Histological Lung Cancer Specimens</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Carcinoma , Small Cell</mesh_term>
	<criteria>Samples must collect manner compliant local ethic committee guidance Samples must originate participant diagnose NSCLC SCLC Participants must pair least one cytological one histological specimen : Both originate inside thorax exthoracic site ; Are confirm collect within window 6 week apart ; compliance protocol define sample requirement histological cytological specimen Immune checkpoint inhibitor therapy 4 week prior collection first tumor sample collection second match sample</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>